{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T06:44:24Z","timestamp":1700549064854},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1097\/ftd.0b013e31802bb194","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T08:58:32Z","timestamp":1171529912000},"page":"40-44","source":"Crossref","is-referenced-by-count":7,"title":["High Plasma Concentrations of Paroxetine Impede Clinical Response in Patients With Panic Disorder"],"prefix":"10.1097","volume":"29","author":[{"given":"Takashi","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikito","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genta","family":"Hirokane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiyo","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Okawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210129","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.pnpbp.2005.11.007","article-title":"The impact of CYP2D6 genotypes on the plasma concentration of paroxetine in Japanese psychiatric patients.","volume":"30","author":"Ueda","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R2-6-20210129","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00228-004-0792-6","article-title":"Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine.","volume":"60","author":"Sawamura","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"R3-6-20210129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2004-818990","article-title":"Paroxetine in major depression: correlating plasma concentrations and clinical response.","volume":"37","author":"Normann","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"R4-6-20210129","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-0447.1989.tb07201.x","article-title":"Paroxetine plasma levels: lack of correlation with efficacy or adverse events.","volume":"350","author":"Tasker","year":"1989","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R5-6-20210129","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-2005-864121","article-title":"Paroxetine serum concentrations in depressed patients and response to treatment.","volume":"38","author":"Gilles","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-2007-979327","article-title":"Serum concentrations of fluvoxamine and clinical effects. A prospective open clinical trial.","volume":"31","author":"Hartter","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"R7-6-20210129","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-2007-979311","article-title":"Fluvoxamine or placebo in the treatment of panic disorder and relationship to blood concentrations of fluvoxamine.","volume":"31","author":"Sandmann","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"R8-6-20210129","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1176\/ajp.155.11.1570","article-title":"Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.","volume":"155","author":"Michelson","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R9-6-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004850-199506000-00003","article-title":"Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale.","volume":"10","author":"Bandelow","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"R10-6-20210129","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1192\/bjp.141.5.518","article-title":"The Clinical Anxiety Scale: an instrument derived from the Hamilton Anxiety Scale.","volume":"141","author":"Snaith","year":"1982","journal-title":"Br J Psychiatry"},{"key":"R11-6-20210129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-1781(97)00118-2","article-title":"The use of the Panic and Agoraphobia Scale in a clinical trial.","volume":"77","author":"Bandelow","year":"1998","journal-title":"Psychiatry Res"},{"key":"R12-6-20210129","first-page":"354","article-title":"Determination of etizolam in human serum or plasma using automated column-switching high-performance liquid chromatography Jpn J Clin Chem.","volume":"19","author":"Hikida","year":"1990","journal-title":""},{"key":"R14-6-20210129","first-page":"435","article-title":"Use of low-dose fluoxetine in major depression and panic disorder.","volume":"54","author":"Louie","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"854","DOI":"10.4088\/JCP.v63n1001","article-title":"Independent actions on fear circuits may lead to therapeutic synergy for anxiety when combining serotonergic and GABAergic agents.","volume":"63","author":"Stahl","year":"2002","journal-title":"J Clin Psychiatry"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e31802bb194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:34:39Z","timestamp":1620952479000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-200702000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31802bb194","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}